SCHEMBL4781301

SCHEMBL4781301

CN1CCN(c2n[nH]c3cc(C(=O)NCc4ccccc4)ccc23)CC1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.54
MAPK1 P28482 2/20 0.51
MAPK3 P27361 1/20 0.51
MAPK10 P53779 1/20 0.51
KIT P10721 6/20 0.51
FLT3 P36888 5/20 0.51
IMPDH2 P12268 1/20 0.50
ITK Q08881 1/20 0.50
KMT2A Q03164 1/20 0.50
ALDH1A1 P00352 2/20 0.49
KDM4E B2RXH2 1/20 0.49
GLA P06280 1/20 0.49
GAA P10253 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
PDGFRB P09619 1/20 0.49
FGFR1 P11362 1/20 0.49
KDR P35968 1/20 0.49
TP53 P04637 2/20 0.48
MAPT P10636 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4784235 0.90 KMT2A (0.51) AURKAMAPK10KITKMT2ASMN1; SMN2
SCHEMBL4783741 0.88 KIT (0.52) MAPK10KITFLT3KMT2AALDH1A1
SCHEMBL4783423 0.88 KIT (0.51) AURKAMAPK10KITFLT3KMT2A
SCHEMBL4784112 0.85 ALDH1A1 (0.54) MAPK1MAPK10KITFLT3KMT2A
SCHEMBL4785037 0.85 RAB9A (0.54) KMT2AALDH1A1KDM4EGAASMN1; SMN2
SCHEMBL4783322 0.82 KMT2A (0.51) AURKAMAPK1MAPK3MAPK10FLT3
SCHEMBL4783835 0.82 DDR1 (0.53) MAPK1
SCHEMBL4780938 0.81 MAPK1 (0.48) MAPK1KITFLT3
SCHEMBL4781936 0.81 FLT3 (0.52) AURKAMAPK1KITFLT3FGFR1
SCHEMBL14173391 0.81 KIT (0.66) MAPK1KITFLT3KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080153810-A1 INDAZOLE DERIVATIVES USEFUL AS MELANIN CONCENTRATING RECEPTOR LIGANDS FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-06-26 US claimed
WO-2008061109-A2 INDAZOLE DERIVATIVES USEFUL AS MELANIN CONCENTRATING RECEPTOR LIGANDS FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-05-22 WO claimed
US-20080153810-A1 INDAZOLE DERIVATIVES USEFUL AS MELANIN CONCENTRATING RECEPTOR LIGANDS FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-06-26 US disclosed
US-20080153810-A1 INDAZOLE DERIVATIVES USEFUL AS MELANIN CONCENTRATING RECEPTOR LIGANDS FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-06-26 US disclosed
US-20080153810-A1 INDAZOLE DERIVATIVES USEFUL AS MELANIN CONCENTRATING RECEPTOR LIGANDS FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-06-26 US disclosed
WO-2008061109-A2 INDAZOLE DERIVATIVES USEFUL AS MELANIN CONCENTRATING RECEPTOR LIGANDS FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-05-22 WO disclosed
WO-2008061109-A2 INDAZOLE DERIVATIVES USEFUL AS MELANIN CONCENTRATING RECEPTOR LIGANDS FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153810-A1 INDAZOLE DERIVATIVES USEFUL AS MELANIN CONCENTRATING RECEPTOR LIGANDS MCHR1, MCHR2, MC1R AURKA 3230/4885MAPK1 3438/4885MAPK3 1856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.